Purpose: To evaluate the influence of the partner (never smoker, ex-smoker or current smoker) with regards to quitting smoking amongst high CVD risk smokers (those who have experienced an event or are at high risk of CVD) during their attendance at a nurse-led, family centred, comprehensive preventive cardiology programmes across Europe, the UK and Ireland.
Methods: In the EUROACTION trial, EUROACTION plus trial, MyAction Galway and MyAction Westminster programmes, coronary patients and high CVD risk patients were recruited from hospitals and general practice, with their partners, to preventive cardiology programmes. Success rate for quitting smoking amongst high CVD risk smokers was measured at the end of the programme.
Results: 222 current smokers and their partners attended the initial and the end of the programme assessments. At the initial assessment, no patients and 55% of the partners were meeting the European goal (smoking abstinence), whilst at the end of the programme 64% and 75% sustained abstinence, respectively. The odds of quitting smoking at 16 weeks were significantly higher (5.83) in couples who tried to quit together (p=0.0001).
Conclusion: During the course of the preventive cardiology programme couples who tried to quit together achieved higher rates of smoking abstinence. Efforts to support smokers in quit attempts should include partners or other family members rather than on individuals alone.